Transcript
Page 1: HOW TECHNOLOGY CAN EVOLVE IMAGING STRATEGIES TO … · 2020. 4. 9. · imaging data in support of their efficacy and safety claims, trial leaders can reduce inherent imaging-related

Manual image collection and management

TECH-DRIVEN APPROACHES

Faster, less expensive, higher quality data

Unnecessary risk and delays from inconsistencies and errors

Time-consuming manual image assessments

Subjective assessment with arbitrary scoring

Sophisticated use of technology and algorithms for each specific protocol

Validation and QC as the reader focus vs. reading every image

Guided and intuitive read platform enables complete and consistent data

Objective results — without the typical human bias

OSTEOARTHRITIS (STEM CELL THERAPY)

UROLOGY (INTERSTITIAL CYSTITIS)

Trimmed read turnaround times

for tumor response reads

CARDIOVASCULAR (AORTIC ANEURYSM REPLACEMENT) ONCOLOGY

ONCOLOGYMUSCULOSKELETAL

(SCOLIOSIS)

ELIMINATED 10 HUMAN-DRIVEN

ERRORS TOP 5 READERS

common to tumor response assessments

to significantly reduce or eliminate intra-/inter-reader variability and improve data

quality & objectivity

ReplacedONCOLOGY

UROLOGY (INTERSTITIAL CYSTITIS)

Traditional imaging methods, characterized by manual and non-standardized processes, amplify many of the challenges surrounding the collection and analysis of images in clinical trials. Transitioning to an expert-driven, automated approach can help you overcome these challenges and brings a myriad of benefits to clinical

studies, including data objectivity, consistency and transparency — all of which support better, faster decisions.

HOW TECHNOLOGY CAN EVOLVE IMAGING STRATEGIES TO IMPROVE

COMPLIANCE AND ENSURE SUCCESS

Reduced MRI procedure time from

and cut costs from2.5 TO 1 HOUR

UP TO 80%

Minimized oncology response criteria errors by

UP TO 30%

CUT TIME IN HALF

$5K TO $2K

Decreased image acquisition time from

10 TO 3 MIN

Reduced X Ray reads from

and cut costs by90 TO 45 MIN

50%

As regulatory agencies continue to push sponsors for more quantitative imaging data in support of their efficacy and safety claims, trial leaders can

reduce inherent imaging-related risks by replacing error-prone manual processes with proven imaging technology.

ERT’s expert-driven, purpose-built technology provides streamlined regulatory compliance, shorter approval timelines, less rework and greater

efficiencies throughout your trial — giving you confidence at every turn.

@ERTglobal

REV 12APRIL2018 | ©2018 ERT. All rights reserved.

@ERT

Learn how ERT’s imaging solutions can minimize imaging risk and uncertainty in your trial at ert.com/imaging

CONFIDENCE IN YOUR IMAGING DATA. CONFIDENCE IN YOUR TRIAL RESULTS.

TRADITIONAL APPROACHES

Time-consuming, labor-intensive, error-prone

Top Related